Tumor induction in mouse liver: Di-isononyl phthalate acts via peroxisome proliferation

Regulatory Toxicology and Pharmacology

Volumn 36, Issue 2, 2002, Pages 175-183

  Kaufmann, W ^a   Deckardt, K ^a   McKee, R H ^b,e   Butala, J H ^c   Bahnemann, R ^d  

^a BASF SE   (Germany)

^b EMBSI   (United States)

^c Aristech Chemical Corporation   (United States)

^d BASF Corporation   (United States)

^e NONE   (United States)

Author keywords

Di isonyl phthalate; Liver tumors; Peroxisomal proliferation

Indexed keywords

PHTHALIC ACID; PHTHALIC ACID DIISONONYL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; LIVER; LIVER TUMOR; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; RESEARCH;

EID: 0036979584     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2002.1575     Document Type: Article

References (42)

1. Ashby, J., Brady, A., Elcombe, C., Elliott, B., Ishmael, J., Odum, J., Tugwood, J., Kettle, S., and Purchase, I. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13 (Suppl. 2), S1-S117.
2. Bahnemann, R. (2000). Cell proliferation in the liver: A malpractice not to measure the zonal distribution? Comparison of the lobule-dependent zonal measurement method with the common method of randomly distributed measurement fields. Toxicol. Methods 10, 81-97.
3. Bahnemann, R., and Mellert, W. (1997). Lobule-dependent zonal measurement (LZM) method for the determination of cell proliferation in the liver. Exp. Toxicol. Pathol. 49, 189-196.
4. Baker, T., Kalimi, G., Lington, A., Isenberg, J., Klaunig, J., and Nikiforov, A. (1996). Gap junctional intercellular communication (GJIC) studies for 5-phthalate monoesters in hepatocytes of four species: Implications for cancer risk assessment. Toxicologist 30, 208.
5. Barber, E., Astill, B., Moran, E., Schneider, B., Gray, T., Lake, B., and Evans, J. (1987). Peroxisome induction studies on seven phthalate esters. Toxicol. Ind. Health 3, 7-22.
6. Barber, E., Cifone, M., Rundell, J., Przygoda, R., Astill, B., Moran, E., Mulholland, A., Robinson, E., and Schneider, B. (2000). Results in the L5178Y mouse lymphoma and the in vitro transformation of Balb 3T3 cell assays for eight phthalate esters. J. Appl. Toxicol. 20, 69-80.
7. Benford, D., Patel, S., Reavy, H., Mitchell, A., and Sarginson, N. (1986). Species differences in the response of cultured hepatocytes to phthalate esters. Food Chem. Toxicol. 24, 799-800.
8. Bichet, N., Cahard, D., Fabre, G., Reandet, B., Gouy, D., and Cano, J. (1990). Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepa-tocytes in primary culture. Toxicol. Appl. Pharmacol. 106, 509-517.
9. Bird, M., Kapp, R., Keller, A., and Lington, A. (1986). A thirteen week feeding study on diisononyl phthalate (DINP) in rats. Toxicologist 6, 302.
10. Butala, J., Moore, M., Cifone, M., Bankston, J., and Astill, B. (1996). Oncogenicity study of di(isononyl) phthalate in rats. Toxicologist 30, 202.
11. Butala, J., Moore, M. Cifone, M., Bankston, J., and Astill, B. (1997). Oncogenicity study of di(isononyl) phthalate in mice. Toxicologist 36, 173.
12. Cattley, R., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B., Marsman, D., Pastoor, T., Popp, J., Robinson, D., Schwetz, B., Tugwood, J., and Wahli, W. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul. Toxicol. Pharmacol. 27, 47-60.
13. David, R., Moore, M., Cifone, M., Finney, D., and Guest, D. (1999). Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci. 50, 195-205.
14. Dunnett, C. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096-1121.
15. Dunnett, C. (1964). New tables for multiple comparisons with a control. Biometrics 20, 482-491.
16. Elcombe, C., and Mitchell, A. (1986). Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): Species differences and possible mechanisms. Environ. Health Perspect. 70, 211-219.
17. Fahimi, H. (1969). Cytochemical localization of peroxidatic activity of catalase in rat hepatic microbodies (peroxisomes). J. Cell Biol. 43, 275-288.
18. Federal Republic of Germany (FRG) (1994). Chemikaliengesetz Bun-desgesetzblatt, Teil 1, 29.07.94.
19. Goll, V., Alexandre, E., Viollon-Abadie, C., Nicod, L., Jaeck, D., and Richert, L. (1999). Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol. Appl. Pharmacol. 160, 21-32.
20. Hall, M., Matthews, A., Webley, L., and Harling, R. (1999). Effects of di-isononyl phthalate (DINP) on peroxisomal markers in the marmoset: DINP is not a peroxisomal proliferator. J. Toxicol. Sci. 24, 237-244.
21. Hasmall, S., James, N., Macdonald, N., West, D., Chevalier, S., Cosulich, S., and Roberts, R. (1999). Suppression of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): A comparison of rat and human hepatocytes in vitro. Arch. Toxicol. 73, 451-456.
22. International Agency for Research on Cancer (IARC) (1995). Peroxi-some Proliferation and Its Role in Carcinogenesis: Views and Expert Opinions of an IARC Working Group, Lyon, 7-11 December, 1994. IARC Technical Rep. 24. IARC, Lyon.
23. International Agency for Research on Cancer (IARC) (2000). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Industrial Chemicals, Vol. 77, 15-22 February 2000.
24. Kamendulis, L., Isenberg, J., Smith, J., Pugh, G., Lington, A., and Klaunig, J. (2002). Comparison of phthalate monoesters on gap junctional intercellular communication and peroxisome proliferation in rodent and human hepatocytes. J. Toxicol. Environ. Health 65, 569-588.
25. Kluwe, W., Haseman, J., Douglas, J., and Huff, J. (1982). The carcinogenicity of dietary di(2-ethylhexyl)phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J. Toxicol. Environ. Health 10, 797-815.
26. Kurata, Y., Kidachi, F., Tokoyama, M., Toyota, N., Tsuchitani, M., and Katoh, M. (1998). Subchronic toxicity of di(2-ethylhexyl) phthalate in common marmosets: Lack of peroxisomal proliferation, testicular atrophy or pancreatic acinar cell hyperplasia. Toxicol. Sci. 42, 49-56.
27. Lazarow, P. (1981). Assay of peroxisomal β-oxidation of fatty acids. Methods Enzymol. 72, 315-319.
28. Lington, A., Bird, M., Plutnick, R., Stubblefield, W., and Scala, R. (1997). Chronic toxicity and carcinogenic evaluation of diisononyl phthalate in rats. Fundam. Appl. Toxicol. 36, 79-89.
29. McKee, R., Przygoda, R., Chirdon, M., Engelhardt, G., Stanley, M. (2000). Di-isononyl phthalate (DINP) and di-isodecyl phthalate (DIDP) are not mutagenic. J. Appl. Toxicol. 20, 491-497.
30. Organization for Economic Coorperation and Development (OECD) (1981). Principles of Good Laboratory Practice. OECD, Paris.
31. Peters, J., Cattley, R., and Gonzalez, F. (1997). Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18, 2029-2033.
32. Pugh, G., Isenberg, J., Kamendulis, L., Clare, L., Brown, W., Lington, A., Ackley, D., Smith, J., and Klaunig, J. (2000). Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate and clofibrate in cynomolgus monkeys. Toxicol. Sci. 56, 181-188.
33. Rappaport, A. (1963). Acinar units and the pathophysiology of the liver. In The Liver, (Ch. Rouiller, Ed.), Vol. 1, pp. 265-328. Academic Press, New York.
34. Rappaport, A. (1980). Hepatic bloodflow: Morphologic aspects and physiologic regulation. In Liver and Biliary Tract Physiology (N. Javitt, Ed.), International Review of Physiology, Vol 21, Univ. Press, Baltimore, MD.
35. Shaw, D., Lee, R., and Roberts, R. (2002). Species differences in response to the phthalate plasticizer monoisononyl phthalate (MINP) in vitro: A comparison of rat and human hepatocytes. Toxicologist 66 (1-S), 37.
36. Siegel, S. (1956). Non-parametric Statistics for Behavioral Sciences. McGraw-Hill, New York.
37. Smith, J., Isenberg, J., Pugh, G., Kamendulis, L., Ackley, D., Lington, A., and Klaunig, J. (2000). Comparative in vivo hepatic effects of di-isononyl phthalate (DINP) and related C7-C11 dialkyl phthalates on gap junctional intercellular communication (GJIC), peroxisomal beta-oxidation (PBOX) and DNA synthesis in rat and mouse liver. Toxicol. Sci. 54, 312-321.
38. Valles, E., Laughter, A., Dunn, C., Cattley, R., and Corton, J. (2000). Role of PPAR alpha in hepatic responses to diisononyl phthalate (DINP). Toxicologist 54, 418.
39. Ward, J., Peters, J., Perella, C., and Gonzalez, F. (1998). Receptor and nonreceptor-mediated, organ-specific toxicity of di(2-ethylhexyl) phthalate (DEHP) in peroxisome proliferator-activated alpha-null mice. Toxicol. Pathol. 26, 240-246.
40. Weichselbaum, T. (1946). An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Am. J. Clin. Pathol. 16, 40-49.
41. Wolfe, G. (1992). A 13-week subchronic dietary oral toxicity study in mice with di(isononyl)phthalate including ancillary hepatocellular proliferation and biochemical analyses. Unpublished laboratory report.
42. Zeiger, E., Haworth, S., Mortelmans, K., and Speck, W. (1985). Mutagenicity testing of di-2(ethylhexyl) phthalate and related chemicals in Salmonella. Environ. Mutagen. 7, 213-232.